With competing risks failure time data, one often needs to assess the covariate effects on the cumulative incidence probabilities. Fine and Gray proposed a proportional hazards regression model to directly model the subdistribution of a competing risk. They developed the estimating procedure for right-censored competing risks data, based on the inverse probability of censoring weighting. Right-censored and left-truncated competing risks data sometimes occur in biomedical researches. In this paper, we study the proportional hazards regression model for the subdistribution of a competing risk with right-censored and left-truncated data. We adopt a new weighting technique to estimate the parameters in this model. We have derived the large samp...
Generally, survival analysis is a significant aspect of statistics that helps in anticipating possib...
Many biomedical and clinical studies with time-to-event outcomes involve competing risks data. These...
One major aspect in medical research is to relate the survival times of patients with the relevant c...
With competing risks failure time data, one often needs to assess the covariate effects on the cumul...
For competing risks data, the Fine–Gray proportional hazards model for subdistribution has gained po...
In survival analysis, the failure time of an event is interval-censored when the event is only known...
In assessing time to event endpoints, data are said to exhibit competing risks if subjects can fail ...
Abstract Background The analysis of time-to-event data can be complicated by competing risks, which ...
In this paper we describe flexible competing risks regression models using the comp.risk() function ...
We consider a competing risks setting, when evaluating the prognostic influence of an exposure on a ...
Failure times are often right-censored and left-truncated. In this paper we give a mass redistributi...
Clinical trials and cohort studies that collect survival data frequently involve patients who may fa...
A population average regression model is proposed to assess the marginal effects of covariates on th...
In clinical and epidemiological studies, competing risks data arise when the subject can experience ...
The cumulative incidence is the probability of failure from the cause of interest over a certain tim...
Generally, survival analysis is a significant aspect of statistics that helps in anticipating possib...
Many biomedical and clinical studies with time-to-event outcomes involve competing risks data. These...
One major aspect in medical research is to relate the survival times of patients with the relevant c...
With competing risks failure time data, one often needs to assess the covariate effects on the cumul...
For competing risks data, the Fine–Gray proportional hazards model for subdistribution has gained po...
In survival analysis, the failure time of an event is interval-censored when the event is only known...
In assessing time to event endpoints, data are said to exhibit competing risks if subjects can fail ...
Abstract Background The analysis of time-to-event data can be complicated by competing risks, which ...
In this paper we describe flexible competing risks regression models using the comp.risk() function ...
We consider a competing risks setting, when evaluating the prognostic influence of an exposure on a ...
Failure times are often right-censored and left-truncated. In this paper we give a mass redistributi...
Clinical trials and cohort studies that collect survival data frequently involve patients who may fa...
A population average regression model is proposed to assess the marginal effects of covariates on th...
In clinical and epidemiological studies, competing risks data arise when the subject can experience ...
The cumulative incidence is the probability of failure from the cause of interest over a certain tim...
Generally, survival analysis is a significant aspect of statistics that helps in anticipating possib...
Many biomedical and clinical studies with time-to-event outcomes involve competing risks data. These...
One major aspect in medical research is to relate the survival times of patients with the relevant c...